Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies

Irwin, David J., Cohen, Todd J., Grossman, Murray, Arnold, Steven E., Xie, Sharon X., Lee, Virginia M.-Y., Trojanowski, John Q.·2012·Brain
DOI 10.1093/brain/aws013

Cited by (282)

Items 201–282 of 282

  1. Human neuronal cells: epigenetic aspects
    Jessica Kukucka, Tessa Wyllie, Justin L. Read, Lauren Mahoney, Cenk Suphioglu · 2013 · BioMolecular Concepts
  2. Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
    Florence Haut, Elentina K. Argyrousi, Ottavio Arancio · 2023 · International Journal of Molecular Sciences
  3. Proteomic insights into lysine acetylation and the implications for medical research
    Ramiro Alonso-Bastida, Sergio Encarnación‐Guevara · 2018 · Expert Review of Proteomics
  4. Biological functions and therapeutic potential of acylation by histone acetyltransferases
    Nan Li, Clark Hamor, Yahang An, Licheng Zhu, Yusheng Gong, Yukimatsu Toh, Yusong R. Guo · 2023 · Acta Materia Medica
  5. Diverse influences on tau aggregation and implications for disease progression
    Meaghan Van Alstyne, James Pratt, Roy Parker · 2025 · Genes & Development
  6. Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons
    Yoonah R. Oh, Min‐Kyoo Shin · 2025 · BMB Reports
  7. Tau Liquid–Liquid Phase Separation in Alzheimer’s Disease: Mechanisms, Pathogenesis, and Therapeutic Implications
    Shijiao Tian, Yan Liu, Hu Hong, Shenghong Li · 2025 · Molecular Neurobiology
  8. Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias
    Pia Kivisäkk, Hadia A. Fatima, Chao‐Yi Wu, Nikhil Padmanabhan, Daniel Romero, Taron Gorham, Molly Weik, Hiroko H. Dodge, Clemens R. Scherzer, Sudeshna Das et al. · 2026 · Neurology
  9. Molecular insights into physiological impact of micro- and nano-plastics on the digestive system and gut-brain axis
    Yuvika, Deepansh Sharma, Ashima Sharma · 2026 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
  10. Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
    Allie N. Greene, Matia B. Solomon, Lisa M. Privette Vinnedge · 2022 · Frontiers in Aging Neuroscience
  11. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease
    Miles R. Bryan, Xu Tian, Jui‐Heng Tseng, Baggio Evangelista, Joey V. Ragusa, Audra F. Bryan, Winifred Trotman, David John Irwin, Todd J. Cohen · 2024 · Acta Neuropathologica Communications
  12. Adenosine Receptors in Alzheimer’s Disease
    Paula M. Canas, Rodrigo Antunes Cunha, Paula M. Agostinho · 2018 · Springer eBooks
  13. Animal models of tau propagation in Alzheimer's disease
    Masami Masuda‐Suzukake, Shotaro Shimonaka, Takashi Nonaka, Masato Hasegawa · 2025 · Neuroscience Research
  14. Investigational therapeutics for the treatment of progressive supranuclear palsy
    David G. Coughlin, Irene Litvan · 2022 · Expert Opinion on Investigational Drugs
  15. Astrocyte–Neuron Interactions in Alzheimer’s Disease
    Clara Muñoz‐Castro, Alberto Serrano‐Pozo · 2024 · Advances in neurobiology
  16. Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation
    Ethan D. Smith, Jose Torrellas, Robert McKenna, Quan Vo, Mario Mietzsch, David Borchelt, Stefan Prokop, Paramita Chakrabarty · 2025 · Journal of Neurochemistry
  17. SIRT1: A Novel Way to Target Tau?
    Hunter S. Futch, Cara L. Croft · 2018 · Journal of Neuroscience
  18. Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
    Yu-Juan Jia, Yi‐Jun Ge, Bowei Li, Ying Yang, Huaqiu Chen, Jie Liu, Junhong Guo, Jin‐Tai Yu, Keqiang Ye, Jian‐Zhi Wang et al. · 2026 · Science China Life Sciences
  19. An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
    Madison I. J. Honey, Yanaika S. Hok‐A‐Hin, Elisabeth H. Thijssen, Katheryn A Q Cousins, Babette van der Weijden, Lisanne in ‘t Veld, Erik Stoops, Sterre C.M. de Boer, Flora Hillegonde Duits, Julie F. H. De Houwer et al. · 2026 · Nature Medicine
  20. Making tau amyloid models in vitro: a crucial and underestimated challenge
    Julien Broc, Clara Piersson, Yann Fichou · 2025 · FEBS Letters
  21. Hippocampal SIRT1 improves cognitive impairment by deacetylating tau protein in diabetic models
    Naihao Shi, Yuwen Lin, Binbin Yan, Xiaowei Jiao, Xiaobao Ding, Yuqing Wu, Chenghua Zhou · 2021 · European Journal of Pharmacology
  22. Assessment of Neurodegenerative Changes in Turkeys Fed Diets with Different Proportions of Arginine and Methionine Relative to Lysine
    Magdalena Krauze, Katarzyna Ognik, D. Mikulski, J. Jankowski · 2022 · Animals
  23. Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation
    Haiyang Zhong, Hongli Liu, Huanxiang Liu · 2023 · Current Medicinal Chemistry
  24. GLP-1 receptor agonist semaglutide ameliorates motor deficits and tau pathology in the rTg4510s mouse model
    Meng-Wei Zhang, Wan-Yi Zhou, Xinyi Li, Zhiheng Xu, Hua-Mei Lin, Yilin Tang, Jue Zhao, Chen Chen, Fengtao Liu, Yimin Sun et al. · 2025 · Neuropharmacology
  25. From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment
    Artur Galushkin, Illana Gozes · 2024 · Current Research in Biotechnology
  26. Molecular profiling in Parkinsonian syndromes: CSF biomarkers
    Federico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti · 2020 · Clinica Chimica Acta
  27. Tau Fibrillogenesis
    Nitin Chaudhary, Ramakrishnan Nagaraj · 2012 · Sub-cellular biochemistry/Subcellular biochemistry
  28. Conformational dynamics of Tau in the cell quantified by an intramolecular FRET biosensor in physiological and pathological context
    Cristina Di Primio, Valentina Quercioli, Giacomo Siano, Branislav Kováčech, M Novák, Antonino Cattaneo · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  29. SUMO inhibits Tau aggregation in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Nagaraj Rangappa · 2025 · Advances in protein chemistry and structural biology
  30. Long-term gabapentin treatment impairs cognitive function in aged mice via tau hyperphosphorylation
    Suyun Xia, Zerong You, Xinbo Wu, Jinsheng Yang, Shiyu Wang, Na Li, Jiajia Dai, Yuanlin Dong, Lucy L Chen, Min Yan et al. · 2025 · Frontiers in Pharmacology
  31. Post-translational modifications as a regulatory code for tau function in health and disease
    Abigail J. Nordbeck, Bhirisha Sharma, Charles A. Garcia, Jui‐Heng Tseng · 2026 · Frontiers in Dementia
  32. Acetylation encodes Tau aggregation
    Youqi Tao, Dan Li · 2023 · Structure
  33. Molecular Pathways in Alzheimer’s Disease and Cognitive Function
    Xu Chen, Meredith C. Reichert, Li Gan · 2016 · Elsevier eBooks
  34. The α-Tubulin Deacetylase HDAC6 in Aggresome Formation and Autophagy
    Christiane Richter‐Landsberg · 2015 · Elsevier eBooks
  35. Insights to develop tau‐directed therapeutics to protect the synaptic integrity for tauopathies
    Eunji Cha, Hak Joong Kim, Sang Min Lim · 2023 · Bulletin of the Korean Chemical Society
  36. Protective association of HLA-DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences
    Emmanuel Jean-Marie Mignot, Yann Le Guen, Guo Luo, Aditya Ambati, Vincent Damotte, Iris E. Jansen, Eric Yu, Aude Nicolas, Itziar de Rojas, Thiago Peixoto Leal et al. · 2022 · Research Square
  37. Chidamide enhances the sensitivity of gastric cancer to 5-fluorouracil chemotherapy by suppressing the HDAC3/HNF4A/TYMS axis
    Xiaofei Zhang, Lei Shi, Yaping Gao, Chenyi Zhou, Xiyin Wang, Xiaonan Shi · 2025 · Cell Death and Disease
  38. Alzheimer’s disease
    Charles J. Duyckaerts · 2014 · Cambridge University Press eBooks
  39. Protein Lysine Acetylated/Deacetylated Enzymes and the Metabolism-Related Diseases
    Qilin Wang, Shangjing Guo, Yaman Gao · 2016 · Advances in Bioscience and Biotechnology
  40. Protein Misfolding, Neurodegeneration and Tau
    Pierfausto Seneci · 2015 · Elsevier eBooks
  41. Frontotemporal lobar degeneration
    Boram Kim, Ashley Viera-Ortiz, Jessica M. Phan, David John Irwin, Edward B. Lee · 2022 · Elsevier eBooks
  42. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
    Bruno Vasconcelos, Matthew Bird, Ilie‐Cosmin Stancu, Dick Terwel, Ilse Dewachter · 2017 · Elsevier eBooks
  43. Tau Protein: Targets And Development Against Alzheimer’s Disease
    Sonal Dubey, Mahesh AR · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  44. Impact of Lysine Acetylation Mutations on the Structure of Full-Length Tau Fibrils
    Aurelio James Dregni, Mei Hong · 2025 · ACS Chemical Neuroscience
  45. On the potential roles of TDP-43 in the formation of membraneless organelles and their transformation into toxic aggregates
    Olga S. Sergeeva, Margarita V. Neklesova, Vladislav A. Reushev, Alexey V. Artemov, Туроверов Константин Константинович, Туроверов Константин Константинович, Vladimir Nikolaevich Uversky, Alexander V. Fonin · 2025 · Biochemical and Biophysical Research Communications
  46. Effect of site-specific lysine acetylation on tau binding to microtubules: mechanistic insights from all-atom molecular dynamics simulations
    Pengxuan Xia, Dushuo Feng, Bote Qi, Lulu Guan, Yunxiang Sun, Yu Zou · 2026 · Physical Chemistry Chemical Physics
  47. Pathogenesis of neurodegenerative diseases via templated recruitment
    Jing Guo · 2013 · ScholarlyCommons (University of Pennsylvania)
  48. Choroba Alzheimera – Rola Badań Immunohistochemicznych W Diagnostyce Choroby = Alzheimer'S Disease - The Role Of Immunohistochemistry In The Diagnosis Of Disease
    Beata Cichacz-Kwiatkowska, Joanna Sekita-Krzak, Katarzyna Kot-Bakiera, Barbara Jodłowska‐Jędrych, Ewelina Wawryk‐Gawda · 2016 · DOAJ (DOAJ: Directory of Open Access Journals)
  49. Pathophysiology and Management Approaches in Alzheimer’s Disease
    Shreshta Jain, Divya Goel, Sheikh Sana Nazir, Vaishali Yadav, Divya Vohora · 2023 · Springer eBooks
  50. Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
    Fieke Prinse, Julie F. H. De Houwer, Elise G.P. Dopper, Harro Seelaar · 2025 · Springer eBooks
  51. Immunotherapy Against Acetylated Tau at K280 Ameliorates Behavioral Impairments and Pathologies of Tau Transgenic Mouse
    Na-Young Kim, Ha‐Lim Song, Kwangmin Cho, Young-Lim Shim, Kyounghye Lee, Yeon‐Seon Mun, Seung‐Eun Lee, Min-Seok Kim, Hyun-Ju Kim, Dong‐Hou Kim et al. · 2020
  52. NEURODEGENERATIVE DISEASES AND TAU: PATHOLOGICAL EVENTS AND MOLECULAR TARGETS
    Pierfausto Seneci · 2012 · Istituto Lombardo - Accademia di Scienze e Lettere - Rendiconti di Scienze
  53. DEVELOPMENT OF A LIVE-CELL ASSAY PLATFORM TO STUDY PROTEIN-PROTEIN INTERACTIONS OF MICROTUBULE-ASSOCIATED PROTEIN TAU
    Niko-Petteri Nykänen · 2012 · UEF eRepo (University of Eastern Finland)
  54. The regulation of phosphorylation of tau protein in Alzheimer's disease
    Di Tang, Han‐Chang Huang, Zhao-Feng Jiang · 2013 · Shengming de Huaxue
  55. Protein Aggregation and Neurodegeneration: Tauopathies and Synucleinopathies
    Michel Goedert · 2017 · Neurodegeneration
  56. SHORT COMMUNICATION Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies
    David John Irwin, Todd J. Cohen, Murray Grossman, Steven Edward Arnold, Vivianna M. Van Deerlin, Y. Lee, John Q. Trojanowski · 2013
  57. The role of tau in Alzheimer’s Disease: Effects of Lys-280 and Lys-281 acetylation on tau function and structure
    Brian H. Constance · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  58. Posttranslational modifications of TDP-43
    Samir Rahman · 2021 · Elsevier eBooks
  59. Cellular Mechanisms of Dementia
    Li Gan · 2017 · Oxford University Press eBooks
  60. Tubulin Modifying Enzymes as Target for the Treatment of Alzheimer's Disease: Old Perspective With A New Angle
    Shweta Shrivastava, Ayush Kumar, Manish Kumar Jeengar, Chandraprabha Sahu · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  61. Molecular and Cellular Mechanisms of Primary Tauopathies
    Shiaoching Gong, Li Gan · 2025 · Oxford University Press eBooks
  62. Additional file 5 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  63. Additional file 6 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Keith W. Nehrke · 2020 · Figshare
  64. Additional file 3 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  65. Additional file 2 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  66. Additional file 4 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  67. Additional file 1 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Keith W. Nehrke · 2020 · Figshare
  68. Étude de l’agrégation des protéines intrinsèquement désordonnées impliquées dans les maladies d’Alzheimer et de Parkinson
    Juan M. Lopez · 2015 · theses.fr (ABES)
  69. Identification et caractérisation des modifications post-traductionnelles de la protéine TAU : implication dans le processus d'agrégation
    Amina Kamah · 2015 · theses.fr (ABES)
  70. Rôle des modifications post-traductionnelles dans le processus d’agrégation de la protéine Tau
    Clément Despres · 2017 · theses.fr (ABES)
  71. Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
    Clément Barbereau · 2020 · theses.fr (ABES)
  72. Identification et caractérisation fonctionnelle de nouveaux sites de clivage de la protéine Tau
    Maxime J. Derisbourg · 2015 · theses.fr (ABES)
  73. Transmission of Alzheimer pathology in murine and primate models : from proteinopathies to neuronal and cognitive impairments
    Suzanne Lam · 2021 · theses.fr (ABES)
  74. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
    真 漆谷, Yoshitaka Tamaki, Makoto URUSHITANI · Institutional Repositories DataBase (IRDB)
  75. Tau Protein in Alzheimer's Disease
    Maitreyee Mukherjee, Soumen Dhara, Abhishek Jana, Tathagata Roy · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  76. Tau-mediated Mechanisms in Alzheimerʼs Disease Pathogenesis
    Tanu Suma Narayanappa, Vaishnavi Ananthanarayana, Subashchandrabose Chinnathambi · 2026 · Molecular Neurobiology
  77. Ultrastructural remodelling of tau fibrils during ghost tangle formation in Alzheimer’s disease brain
    Daniel A. Stähli, Louis Travers, Notash Shafiei, Lukas van den Heuvel, Eglantine Vialaneix, Philippine L Schneider, Annemieke J.M. Rozemüller, Wilma D. J. van de Berg, Henning Stahlberg, Amanda J. Lewis · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Antemortem α-Synuclein levels from neuron-derived extracellular vesicles identify Lewy Body pathology in Parkinson’s Disease and Alzheimer Disease
    Tamil Iniyan Gunasekaran, Dolly Reyes‐Dumeyer, Yian Y Gu, Olga V. Volpert, Doug Beauregard, Lammert Albers, Andrew F. Teich, Lawrence S. Honig, Richard P Mayeux, Erez Eitan et al. · 2026 · medRxiv
  79. Next-generation brain proteomics: Integrating single-cell, spatial, and multi-omics for clinical biomarker discovery
    Arup Acharjee, Nitika Rai, Akash Patel, Papia Acharjee · 2026 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  80. Alcohol-induced dysregulation of tau and acetylation pathways in the pathogenesis of Alzheimer’s disease
    KC Basavaraju, Harshitha D K, Poornima Priyadarshini C. G. · 2026 · Neuroscience
  81. Multivalent ubiquitin recognition regulates multiple stages of Tau self-assembly
    Kevin Muwonge, Luis Fernando Durán-Armenta, Tamás Lázár, Attila Mészáros, Alexander N. Volkov, Alvaro M. Navarro, Cristina Marino‐Buslje, María Laura Fernández, Gustavo J. Gutierrez, Nicholas M. Kanaan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Safe and efficient intracellular delivery of functional antibodies into cultured neural cells shows a role for Alzheimer’s-relevant tau phosphorylation in cell integrity
    Kirsten L. Viola, Brett A. Chromy, Raghad Nowar, Mary P. Lambert, Klein William L. · 2026 · Frontiers in Dementia